+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Cancer Pancreatic Cancer

Epidermal Growth Factor Receptor (EGFR) Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Epidermal Growth Factor Receptor (EGFR) Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • September 2025
  • 92 Pages
  • Global
From
Hepatocyte Growth Factor Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Hepatocyte Growth Factor Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • February 2026
  • 171 Pages
  • Global
From
2023 U.S. Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 U.S. Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • United States
From
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 152 Pages
  • Global
From
2023 Australia Tumor Markers Diagnostic Testing Diagnostic Testing Market Assessment - Oncogenes, Biomarkers Diagnostic Testing Diagnostic Testing, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Australia Tumor Markers Diagnostic Testing Diagnostic Testing Market Assessment - Oncogenes, Biomarkers Diagnostic Testing Diagnostic Testing, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Australia
From
2023 United Arab Emirates Tumor Markers Diagnostic Testing Market Assessment - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 United Arab Emirates Tumor Markers Diagnostic Testing Market Assessment - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • United Arab Emirates United Arab Emirates
From
USA Patient Registry Software Market Outlook to 2028 - Product Thumbnail Image

USA Patient Registry Software Market Outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
2023 U.K. Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 U.K. Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • United Kingdom
From
2023 Spain Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers:, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Spain Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers:, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Spain
From
2023 Japan Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Japan Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Japan
From
2023 Italy Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Italy Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Italy
From
2023 Germany Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Germany Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Germany
From
2023 France Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 France Tumor Markers Diagnostic Testing Market Assessment of Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • France
From
2023 North America Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in the USA, Canada, Mexico - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 North America Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in the USA, Canada, Mexico - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Canada, Mexico, North America Canada, Mexico, North America
From
2023 Asia-Pacific Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 18-Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Asia-Pacific Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 18-Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Asia Pacific
From
2023 Africa Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 7-Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Africa Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 7-Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Africa
From
2023 Middle East Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 11 Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Middle East Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 11 Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Middle East
From
2023 Latin America Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 22 Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Latin America Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 22 Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Latin America
From
Terumo Corp (4543) - Product Pipeline Analysis, 2024 Update - Product Thumbnail Image

Terumo Corp (4543) - Product Pipeline Analysis, 2024 Update

  • Company Profile
  • August 2024
  • 96 Pages
From
2023 Global Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in the USA, Europe, Japan - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies - Product Thumbnail Image

2023 Global Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in the USA, Europe, Japan - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies

  • Report
  • June 2023
  • Japan, United States, ... Japan, United States, Europe, Global
From
Loading Indicator